| EP2283817 - Method of making particles for use in a pharmaceutical composition [Right-click to bookmark this link] | Status | Patent revoked Status updated on 30.11.2022 Database last updated on 11.04.2026 | |
| Former | The patent has been granted Status updated on 25.03.2020 | Most recent event Tooltip | 02.12.2022 | Revocation of patent | published on 04.01.2023 [2023/01] | Applicant(s) | For all designated states Vectura Limited 1 Prospect West Chippenham, Wiltshire SN14 6FH / GB | [2011/07] | Inventor(s) | 01 /
Staniforth, John The Byre Claverton Bath, BA2 7BG / GB | 02 /
Green, Matthew, Michael, James Vectural Limited 5 St Lawrence way Caterham, Surrey, Surrey CR3 5FD / GB | 03 /
Morton, David, Alexander, Vodden Vectura Limited 2nd Floor Flat Linsley House Beechen Cliff House Bath, Bath and North East Somerset BA2 4QR / GB | [2016/20] |
| Former [2011/11] | 01 /
Staniforth, John The Byre Claverton Bath, BA2 7BG / GB | ||
| 02 /
Green, Matthew, Michael, James Vectural Limited 5 St Lawrence way Caterham, Surrey, Surrey CR3 5FD / GB | |||
| 03 /
Morton, David, Alexander, Vodden Vectura Limited 2nd Floor Flat Linsley House Beechen Cliff House Bath, Bath and North East Somerset BA2 4QR / GB | |||
| Former [2011/07] | 01 /
Staniforth, John Vectura Limited High Trees 170 Bloomfield Road Bath, Bath and North East Somerset BA2 2ST / GB | ||
| 02 /
Green, Matthew, Michael, James Vectural Limited 5 St Lawrence way Caterham, Surrey, Surrey CR3 5FD / GB | |||
| 03 /
Morton, David, Alexander, Vodden Vectura Limited 2nd Floor Flat Linsley House Beechen Cliff House Bath, Bath and North East Somerset BA2 4QR / GB | Representative(s) | CMS Cameron McKenna Nabarro Olswang LLP Cannon Place 78 Cannon Street London EC4N 6AF / GB | [N/P] |
| Former [2012/34] | Stephen, Robert John Olswang LLP 90 High Holborn London WC1V 6XX / GB | ||
| Former [2011/07] | McNamara, Kathryn, et al Venner Shipley LLP Byron House Cambridge Business Park Cowley Road Cambridge CB4 0WZ / GB | Application number, filing date | 10181899.5 | 30.11.2001 | [2011/07] | Priority number, date | GB20000029261 | 30.11.2000 Original published format: GB 0029261 | GB20000030946 | 19.12.2000 Original published format: GB 0030946 | WO2001GB01606 | 09.04.2001 Original published format: PCT/GB01/01606 | GB20010024010 | 05.10.2001 Original published format: GB 0124010 | [2011/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2283817 | Date: | 16.02.2011 | Language: | EN | [2011/07] | Type: | B1 Patent specification | No.: | EP2283817 | Date: | 18.05.2016 | Language: | EN | [2016/20] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.12.2010 | Classification | IPC: | A61K9/14, A61K9/72, A61K9/00 | [2011/07] | CPC: |
A61K9/0075 (EP,US);
A61K9/5115 (US);
A61K31/137 (EP,US);
A61K47/06 (US);
A61K47/10 (US);
A61K47/12 (US);
A61K47/32 (US);
A61K47/44 (EP);
A61K9/008 (EP,US);
A61K9/145 (EP,US);
A61K9/1617 (EP,US);
A61K9/167 (US);
A61K9/50 (US);
A61K9/501 (US);
A61K9/5015 (US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2016/20] |
| Former [2011/07] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR | Title | German: | Herstellungsverfahren für Partikel zur Verwendung in einer Arrzneizusammensetzung | [2011/07] | English: | Method of making particles for use in a pharmaceutical composition | [2011/07] | French: | Procédé de préparation de particules destinées à être utilisées dans une composition pharmaceutique | [2011/07] | Examination procedure | 16.08.2011 | Amendment by applicant (claims and/or description) | 16.08.2011 | Examination requested [2011/38] | 05.12.2011 | Despatch of a communication from the examining division (Time limit: M06) | 20.07.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 21.09.2012 | Reply to a communication from the examining division | 19.09.2014 | Despatch of a communication from the examining division (Time limit: M04) | 29.01.2015 | Reply to a communication from the examining division | 02.06.2015 | Despatch of a communication from the examining division (Time limit: M04) | 20.08.2015 | Reply to a communication from the examining division | 04.01.2016 | Communication of intention to grant the patent | 05.04.2016 | Fee for grant paid | 05.04.2016 | Fee for publishing/printing paid | 05.04.2016 | Receipt of the translation of the claim(s) | 30.07.2020 | Observations by third parties | Parent application(s) Tooltip | EP01998328.7 / EP1337240 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010998328) is 02.09.2005 | Opposition(s) | Opponent(s) | 01
16.02.2017
21.02.2017
ADMISSIBLE Glaxo Group Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB Opponent's representative J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2020/35] | |||
| Opponent(s) | 01
16.02.2017
21.02.2017
ADMISSIBLE Glaxo Group Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB Opponent's representative J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
| Former [2017/12] | |||
| Opponent(s) | 01
16.02.2017
Glaxo Group Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB Opponent's representative Gladwin, Amanda Rachel GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | deleted | Deletion: Legal effect of rejection of opposition [ N /P ] | 31.03.2017 | Invitation to proprietor to file observations on the notice of opposition | 10.08.2017 | Reply of patent proprietor to notice(s) of opposition | 04.06.2019 | Date of oral proceedings | 26.03.2020 | Despatch of minutes of oral proceedings | 26.03.2020 | Date of despatch of rejection of opposition | 07.11.2022 | Despatch of communication that the patent will be revoked | 17.11.2022 | Legal effect of revocation of patent [2023/01] | Appeal following opposition | 02.04.2020 | Appeal received No. T0951/20 | 30.07.2020 | Statement of grounds filed | 02.11.2022 | Result of appeal procedure: revocation of the patent | 07.11.2022 | Despatch of the decision of the Board of Appeal | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 21.09.2012 | Request for further processing filed | 21.09.2012 | Full payment received (date of receipt of payment) Request granted | 16.11.2012 | Decision despatched | Fees paid | Renewal fee | 24.01.2011 | Renewal fee patent year 03 | 24.01.2011 | Renewal fee patent year 04 | 24.01.2011 | Renewal fee patent year 05 | 24.01.2011 | Renewal fee patent year 06 | 24.01.2011 | Renewal fee patent year 07 | 24.01.2011 | Renewal fee patent year 08 | 24.01.2011 | Renewal fee patent year 09 | 28.03.2011 | Renewal fee patent year 10 | 29.11.2011 | Renewal fee patent year 11 | 29.11.2012 | Renewal fee patent year 12 | 27.11.2013 | Renewal fee patent year 13 | 26.11.2014 | Renewal fee patent year 14 | 30.11.2015 | Renewal fee patent year 15 | Penalty fee | Additional fee for renewal fee | 30.11.2010 | 10   M06   Fee paid on   28.03.2011 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | GB | 19.12.2019 | IE | 30.11.2021 | ES | 01.12.2021 | PT | 10.12.2021 | [2022/23] |
| Former [2022/11] | GB | 19.12.2019 | |
| IE | 30.11.2021 | ||
| PT | 10.12.2021 | ||
| Former [2022/07] | GB | 19.12.2019 | |
| IE | 30.11.2021 | ||
| Former [2020/37] | GB | 19.12.2019 | Documents cited: | Search | [X] WO0027363 (NANOSYSTEMS et al.) | [X] US5506203 (BAECKSTROEM KJELL G E et al.) | [XD] WO9703649 (CO ORDINATED DRUG DEV LTD et al.) | [X] WO9938493 (RTP PHARMA INC et al.) | [X] US5663198 (REUL BERNHARD et al.) | [X] WO9619199 (ASTRA AB et al.) | Examination | WO0033811 | PEART J ET AL: "MULTICOMPONENT PARTICLE INTERACTIONS IN DRY POWDER AEROSOLS", PHARMACEUTICAL RESEARCH, SPRINGER NEW YORK LLC, US, vol. 14, no. 11-S, 1 January 1997 (1997-01-01), pages S142/S143, XP001030455, ISSN: 0724-8741 | by applicant | WO9703649 | other | GB0029261 | GB0030946 | GB0101606 | GB0124010 | WO0176575 | Opposition | WO0027363 | WO0053158 | WO0053157 | US5145684 | WO9703649 | WO9938493 | WO0243700 | GB0124009 | WO0176575 | GB1381872 | GB0029261 | GB0030946 | GB0101606 | GB0124010 | PEART, JOANNE ET AL.: "Multicomponent particle interactions in dry powder aerosols", PHARMACEUTICAL RESEARCH, vol. 14, 1997, pages S142 - S143, XP001030455 | KAWASHIMA, YOSHIAKI ET AL.: "Design of inhalation dry powder of pranlukast hydrate to improve dispersibility by the surface modification with light anhydrous silicic acid (AEROSIL 200)", INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 173, 1998, pages 243 - 251, XP055190780 DOI: http://dx.doi.org/10.1016/S0378-5173(98)00243-9 | KOISHI, MASUMI ET AL.: "Preparation and surface properties of encapsulated powder pharmaceuticals", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 10, 1984, pages 259 - 262, XP035178042 DOI: http://dx.doi.org/10.1007/BF02783759 |